Proposed Registration Decision PRD2021-07, Cydia pomonella granulovirus isolate V-22 and Madex HP

Proposed Registration Decision PRD2021-07, Cydia pomonella granulovirus isolate V-22 and Madex HP This summary describes the key points of the evaluation, while the Science evaluation of Proposed Registration Decision PRD2021-07, Cydia pomonella granulovirus isolate V-22 and Madex HP provides detailed technical information on the human health, environmental and value assessments of Cydia pomonella granulovirus isolate V-22 and Madex HP. 2023-03-29 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetypesticide safetyregistration decisionPRD2021-07Cydia pomonella granulovirus-isolate-V-22Madex HP Proposed Registration Decision PRD2021-07, Cydia pomonella granulovirus isolate V-22 and Madex HPHTML https://www.canada.ca/en/health-canada/services/consumer-product-safety/pesticides-pest-management/public/consultations/proposed-registration-decisions/2021/cydia-pomonella-granulovirus-isolate-v-22-madex-hp/document.html Proposed Registration Decision PRD2021-07, Cydia pomonella granulovirus isolate V-22 and Madex HPHTML https://www.canada.ca/fr/sante-canada/services/securite-produits-consommation/pesticides-lutte-antiparasitaire/public/consultations/projets-decision-homologation/2021/isolat-v-22-granulovirus-cydia-pomonella-produit-madex-hp/document.html

This summary describes the key points of the evaluation, while the Science evaluation of Proposed Registration Decision PRD2021-07, Cydia pomonella granulovirus isolate V-22 and Madex HP provides detailed technical information on the human health, environmental and value assessments of Cydia pomonella granulovirus isolate V-22 and Madex HP.

Data and Resources

Similar records